StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-17 22:05 UTC

ADMA — ADMA Biologics, Inc.

EXPENSIVE (MOS -40.0%) · Quality 80/100

Price
10.68
Intrinsic value
7.63
Margin of safety
-40.0%
Implied growth (reverse DCF)
+34.1%
model assumes +17.4%
Value Score
16.8
Quality
80
Psychology
-22.7
Discovery
14.7
price/volume attention only
Moat score
77.5
erosion: none

Value Score: bottom 25% of Russell 3000 · Quality: top 5%

Open the interactive Deep Dive for ADMA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ADMA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ADMA undervalued?

As of 2026-10-17, ADMA trades at 10.68 against a computed intrinsic value of 7.63 (-40.0% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is ADMA Biologics, Inc.'s Value Score?

ADMA Biologics, Inc.'s Value Score is 16.8 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.